While the smaller recombinant proteins can be directly extracted from the apoplast fluid, large protein complexes require a conventional purification process. Recombinant proteins may also have ...

Sino Biological is specialized in recombinant protein production and antibody development. Based on its expertise in the construction and screening of phage display antibody libraries, Sino Biological ...

As an initial step in this process, the first chemically defined (CD), yeastolate-free insect cell culture medium, ExpiSf CD Medium, was developed to support high-density cell growth, high-titer ...

App Note: Recombinant protein expression using a baculovirus-insect cell system Review: Cell-free protein synthesis: advances on production process for biopharmaceuticals and immunobiological products ...

This webinar is hosted by Thermo Fisher Scientific in collaboration with the Walter and Eliza Hall Institute of Medical Research (WEHI). The webinar will aim to provide an overview of recombinant ...

For recombinant protein vaccine developers, this includes access to effective GMP-grade adjuvants, which have been known to cause bottlenecks in production.

Insect cell mediated recombinant protein expression Insect cells necessitate the use of an intermediate – baculovirus –to enable protein expression. Baculoviruses are a varied group of DNA ...

Pichia pastoris has emerged as a central microbial host for recombinant protein production, offering a unique balance of rapid growth, capacity for post‐translational modifications, and ease of ...

The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins ...

The first licensed mAb drug is muromonab-CD3 (1986), a hybridoma derived antibody that was used for immunosuppression during organ transplantation. Rituximab (Rituxan), approved by the FDA in 1997, ...